Evaluation and Preservation of Fertility in Patients with Testicular Cancer

Journal of Adolescent and Young Adult Oncology
Siamak DaneshmandCraig Nichols

Abstract

Young men presenting with testicular cancer enjoy a very high prospect of cure and look forward to an average of 40 additional years of life. As such, emphasis has focused on care algorithms that are not only curative, but also minimize the consequences of the disease and associated treatments on subsequent quality of life. Concerns regarding therapy-related second malignancies and cardiovascular disease have led to management strategies emphasizing the reduction or elimination of chemotherapy and radiation therapy and increase utilization of surveillance for early-stage patients. Germ cell tumors present typically in the late 20s or early 30s, occurring in a timeframe when many young men begin to consider their families seriously. Indeed, more than 80% of young patients report significant concerns regarding diminished fertility. The biology and anatomy of most germ cell tumors lead to significant potential for disrupted fertility from both disease-related factors-hypogonadism and diminished native spermatogenesis-and manifold treatment-related complications such as ejaculatory dysfunction, chemotherapy, and radiation effects on spermatogenesis and testosterone production. Despite these unique challenges of managing fertility i...Continue Reading

References

Aug 1, 1990·The Journal of Urology·J P DonohueG Geier
Jun 1, 1988·The Journal of Urology·M A JewettM K Gospodarowicz
Mar 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R E DrasgaE E Stevens
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H LampeD P Dearnaley
Feb 26, 1999·BMJ : British Medical Journal·H Møller, N E Skakkebaek
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P M PetersenA Giwercman
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S D FossåS P Stenning
Sep 29, 2000·BMJ : British Medical Journal·R JacobsenH Moller
Oct 24, 1953·Nature·R G BUNGE, J K SHERMAN
Jul 30, 2004·The New England Journal of Medicine·John K Amory
Jul 29, 2005·Cancer Causes & Control : CCC·V Paul Doria-RoseNoel S Weiss
Jun 17, 2008·Fertility and Sterility·Igor CrhaJiri Jarkovsky
Feb 5, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu MikiAkihiko Okuyama
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gwendolyn P QuinnTerrance L Albrecht
Sep 21, 2010·The Journal of Urology·Stephen D W BeckRichard S Foster

❮ Previous
Next ❯

Citations

Feb 16, 2015·Clinical Genitourinary Cancer·Brian HuSiamak Daneshmand
Feb 1, 2015·Seminars in Oncology Nursing·Pandora PattersonSharon Medlow

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
chromosomal aberrations
contraception
dissection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Oncology Nursing
K Ruble, K P Kelly
Canadian Family Physician Médecin De Famille Canadien
M Brigden, M McKenzie
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Raed A Aqel, Gilbert J Zoghbi
© 2021 Meta ULC. All rights reserved